 | Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Sees Significant Decline in Short Interest
www.americanbankingnews.com - July 11 at 11:13 PM |
 | If You Had Bought Brainstorm Cell Therapeutics (NASDAQ:BCLI) Stock Three Years Ago, You Could Pocket A 59% Gain Today
finance.yahoo.com - July 10 at 8:30 AM |
 | Third Clinical Site Initiated for BrainStorm Cell Therapeutic's Phase 2 Progressive MS Study
www.marketwatch.com - July 2 at 6:40 PM |
| Third Clinical Site Initiated for BrainStorm Cell Therapeutic’s Phase 2 Progressive MS Study
finance.yahoo.com - July 2 at 8:21 AM |
 | BrainStorm Cell Therapeutics (BCLI) Presents At BIO 2019 International Convention - Slideshow
seekingalpha.com - June 6 at 7:07 PM |
| BrainStorm Presents Poster at Consortium of Multiple Sclerosis Centers (CMSC) 33rd Annual Meeting
finance.yahoo.com - May 31 at 8:22 AM |
| BrainStorm Announces Second Clinical Site to Enroll Patients in Its Progressive MS Phase 2 Study
finance.yahoo.com - May 30 at 8:28 AM |
| BCLI: Enrollment in Phase 3 ALS Trial to Complete in 3Q19…
finance.yahoo.com - May 21 at 7:27 PM |
| Brainstorm Cell Therapeutics: Poor Cash And Specific Risks Make This An Avoid
seekingalpha.com - May 16 at 7:45 PM |
| BrainStorm Cell Therapeutics misses by $0.13
seekingalpha.com - May 10 at 6:55 PM |
| BrainStorm’s Cellular Technology Platform Expanded to Include Exosomes for Neurodegenerative Diseases
finance.yahoo.com - April 30 at 8:17 AM |
| BCLI: Two Abstracts to be Presented at AAN Annual Meeting…
finance.yahoo.com - April 4 at 8:07 PM |
| Two BrainStorm Scientific Abstracts Accepted for Presentation at the 71st American Academy of Neurology Annual Meeting
finance.yahoo.com - March 28 at 8:29 AM |
| BrainStorm Announces Grant of an additional New European Patent for NurOwn®
finance.yahoo.com - March 26 at 8:31 AM |
| Atlas Blockchain Announces Definitive Agreement for the Acquisition of Isracann and Amendment to Investor Services Agreement
finance.yahoo.com - March 19 at 8:37 AM |
 | Brainstorm Cell Therapeutics (BCLI) Reports First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS - StreetInsider.com
www.streetinsider.com - March 15 at 7:29 PM |
| BCLI: Hospital Exemption Approved in Israel; First Patient Enrolled in Phase 2 Study in Progressive MS…
finance.yahoo.com - March 15 at 7:29 PM |
| BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS
finance.yahoo.com - March 14 at 8:27 AM |
| Breakeven On The Horizon For Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)
finance.yahoo.com - March 13 at 7:07 PM |
| Brainstorm Cell Therapeutics (BCLI) Reports First Contracted US Clinical Site for Phase 2 Progressive MS Study - StreetInsider.com
www.streetinsider.com - February 23 at 6:11 PM |
| BrainStorm Announces First Contracted U.S. Clinical Site for Phase 2 Progressive MS Study
finance.yahoo.com - February 22 at 8:22 AM |
| BrainStorm to Present at 2019 Sachs Associates European Life Sciences CEO Forum in Zurich, Switzerland
finance.yahoo.com - February 21 at 8:28 AM |
| BrainStorm Issues a Statement to Patients and Shareholders
finance.yahoo.com - February 19 at 8:16 AM |
| BrainStorm to Present at 2019 BIO CEO & Investor Conference and Extracellular Vesicles in Diagnostics & Therapeutics Symposium
finance.yahoo.com - February 5 at 7:16 AM |
| BrainStorm Cell Therapeutics to Present at the 2019 NobleCon15 Annual Investor Conference in Fort Lauderdale, Florida
finance.yahoo.com - January 25 at 8:18 AM |
| BrainStorm Granted Additional Patent for NurOwn® in Israel
finance.yahoo.com - January 22 at 6:24 PM |
| BCLI: Initiating Phase 2 Study in Progressive Multiple Sclerosis…
finance.yahoo.com - January 7 at 6:23 PM |
| BrainStorm Issues 2018 Letter to Shareholders
finance.yahoo.com - December 27 at 8:28 AM |
| BrainStorm Expands Manufacturing of NurOwn® for Phase 2 Progressive MS Trial
finance.yahoo.com - December 26 at 8:22 AM |
| Brainstorm (BCLI) Announces FDA Accepted its NurOwn IND Application for Progressive Multiple Sclerosis
www.streetinsider.com - December 17 at 5:44 PM |
| BrainStorm gets FDA okay for stem cell trial in MS patients
finance.yahoo.com - December 17 at 8:17 AM |
| FDA Accepts BrainStorm’s NurOwn® IND Application for Progressive Multiple Sclerosis
finance.yahoo.com - December 17 at 8:17 AM |
| BrainStorm Cell Therapeutics to Present at the 29th International Symposium on ALS/MND
finance.yahoo.com - December 4 at 8:24 AM |
| Do Institutions Own Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Shares?
finance.yahoo.com - December 3 at 5:15 PM |
 | Detailed Research: Economic Perspectives on Stellar Biotechnologies, MAM Software Group, EverQuote, Brainstorm ...
globenewswire.com - November 22 at 8:19 AM |
| Brainstorm files IND for mid-stage study of NurOwn in progressive MS
seekingalpha.com - November 21 at 8:18 AM |
| Brainstorm Cell Therapeutics (BCLI) Announces Submission of IND for NurOwn in Progressive MS
www.streetinsider.com - November 20 at 8:17 AM |
| BrainStorm Cell Therapeutics Announces Submission of IND for NurOwn® in Progressive Multiple Sclerosis
finance.yahoo.com - November 19 at 8:18 AM |
| BrainStorm Cell Therapeutics to Present at November Clinical and Investor Conferences
finance.yahoo.com - November 7 at 8:18 AM |
| BCLI: Phase 3 Trial to Be Fully Enrolled by Mid-2019…
finance.yahoo.com - October 30 at 5:33 PM |
| BrainStorm Cell Therapeutics net loss widens in Q3
seekingalpha.com - October 29 at 5:03 PM |
| BrainStorm Announces Financial Results for the Third Quarter of 2018 and Provides a Corporate Update
finance.yahoo.com - October 29 at 5:03 PM |
| BrainStorm to Announce Third Quarter Financial Results and Provide Corporate Update on Monday, October 29
finance.yahoo.com - October 17 at 4:58 PM |
| Form DEF 14A BRAINSTORM CELL THERAPEU For: Nov 29
www.streetinsider.com - October 11 at 8:18 AM |
| BrainStorm Poster Receives Clinical Abstract Award at NEALS Conference
globenewswire.com - October 4 at 4:53 PM |
| Does Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI) Fall With The Market?
finance.yahoo.com - October 4 at 4:53 PM |
| BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In ...
globenewswire.com - October 4 at 8:15 AM |
| BrainStorm Highlights Translational Data and Presentations Supporting NUROWN® Technology Platform as a Best-In-Class Strategy in ALS
finance.yahoo.com - October 3 at 8:21 AM |
| Brainstorm Cell Therapeutics (BCLI) Announces New U.S. Patent for Industrial Scale Manufacturing of NurOwn
www.streetinsider.com - September 13 at 4:54 PM |
| BrainStorm Granted New U.S. Patent for Industrial Scale Manufacturing of NurOwn®
finance.yahoo.com - September 13 at 8:25 AM |
